|
US6562347B1
(en)
|
1998-03-12 |
2003-05-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
Chemokine-tumor antigen fusion proteins as cancer vaccines
|
|
KR20020075789A
(ko)
|
2000-02-04 |
2002-10-05 |
듀크 유니버시티 |
인체 면역결핍 바이러스 백신
|
|
WO2001083535A2
(en)
*
|
2000-05-02 |
2001-11-08 |
Simon Fraser University |
Polypeptides for use as a vaccine and/or treatment for hiv infection
|
|
AUPS065002A0
(en)
|
2002-02-20 |
2002-03-14 |
Immunaid Pty Ltd |
Strategy for retroviral immunotherapy
|
|
US20030228320A1
(en)
*
|
2000-08-18 |
2003-12-11 |
Ashdown Martin Leonard |
Retroviral immunotherapy
|
|
US7754676B2
(en)
|
2000-09-15 |
2010-07-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
Defensin-antigen fusion proteins
|
|
AU2001291050A1
(en)
|
2000-09-15 |
2002-03-26 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Viral chemokine-tumur antigen fusion proteins
|
|
EP1361886A2
(en)
*
|
2001-02-15 |
2003-11-19 |
The Gov. of USA, as represented by the Secretary, Dept. of Health and Human services, National Institutes of Health |
Methods and compositions for inhibiting hiv-coreceptor interactions
|
|
AUPS054702A0
(en)
*
|
2002-02-14 |
2002-03-07 |
Immunaid Pty Ltd |
Cancer therapy
|
|
WO2004050856A2
(en)
*
|
2002-12-03 |
2004-06-17 |
University Of Massachusetts |
Polyvalent, primary hiv-1 glycoprotein dna vaccines and vaccination methods
|
|
AU2004247146A1
(en)
*
|
2003-06-12 |
2004-12-23 |
Vaxgen, Inc. |
HIV-1 envelope glycoproteins having unusual disulfide structure
|
|
US8076060B2
(en)
*
|
2003-08-04 |
2011-12-13 |
Emil William Chynn |
Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma
|
|
DK1692516T3
(da)
*
|
2003-10-24 |
2011-02-28 |
Immunaid Pty Ltd |
Terapifremgangsmåde
|
|
DK1805510T3
(da)
*
|
2004-09-08 |
2012-04-30 |
Immunaid Pty Ltd |
Terapeutisk strategi til behandling af autoimmune og degenerative sygdomme
|
|
PT1794327T
(pt)
*
|
2004-09-14 |
2017-01-24 |
Argos Therapeutics Inc |
Amplificação independente de estirpes de patogénios e vacinas para os mesmos
|
|
JP2009509970A
(ja)
*
|
2005-09-22 |
2009-03-12 |
プロサイ インコーポレイテッド |
酵母突然変異体において産生されるグリコシル化ポリペプチドおよびその使用方法
|
|
WO2009017743A2
(en)
|
2007-07-30 |
2009-02-05 |
Argos Therapeutics, Inc. |
Improved primers and probes for the amplification and detection of hiv gag, rev and nef polynucleotides
|
|
KR101701198B1
(ko)
|
2008-06-19 |
2017-02-01 |
배리에이션 바이오테크놀로지스 아이엔씨. |
인플루엔자를 치료하기 위한 조성물 및 방법
|
|
PT2435825E
(pt)
|
2009-05-27 |
2015-11-02 |
Biotempus Ltd |
Métodos para o tratamento de doenças
|
|
MX2012000372A
(es)
|
2009-07-06 |
2012-02-28 |
Variation Biotechnologies Inc |
Metodos para preparar vesiculas y formulaciones producidas a partir de las mismas.
|
|
US9907746B2
(en)
|
2009-07-06 |
2018-03-06 |
Variation Biotechnologies, Inc. |
Methods for preparing vesicles and formulations produced therefrom
|
|
CA2793959C
(en)
|
2010-03-25 |
2019-06-04 |
Oregon Health & Science University |
Cmv glycoproteins and recombinant vectors
|
|
CA2840079C
(en)
|
2010-07-06 |
2018-07-03 |
Variation Biotechnologies Inc. |
Compositions and methods for treating influenza
|
|
US10736844B2
(en)
|
2011-01-13 |
2020-08-11 |
Variation Biotechnologies Inc. |
Compositions and methods for treating viral infections
|
|
SI2691530T1
(en)
|
2011-06-10 |
2018-08-31 |
Oregon Health & Science University |
Cmv glycoproteins and recombinant vectors
|
|
AU2012216792A1
(en)
|
2011-09-12 |
2013-03-28 |
International Aids Vaccine Initiative |
Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
|
|
EP2586461A1
(en)
|
2011-10-27 |
2013-05-01 |
Christopher L. Parks |
Viral particles derived from an enveloped virus
|
|
WO2013104995A2
(en)
|
2012-01-12 |
2013-07-18 |
Variation Biotechnologies, Inc. |
Compositions and methods for treating viral infections
|
|
CN104244984B
(zh)
|
2012-01-27 |
2020-03-31 |
变异生物技术公司 |
用于治疗剂的方法和组合物
|
|
ES2631608T3
(es)
|
2012-06-27 |
2017-09-01 |
International Aids Vaccine Initiative |
Variante de la glicoproteína Env del VIH-1
|
|
WO2014089152A1
(en)
|
2012-12-04 |
2014-06-12 |
University Of Maryland, Baltimore |
Hiv-1 env-binding antibodies, fusion proteins, and methods of use
|
|
US20150065381A1
(en)
|
2013-09-05 |
2015-03-05 |
International Aids Vaccine Initiative |
Methods of identifying novel hiv-1 immunogens
|
|
EP2873423B1
(en)
|
2013-10-07 |
2017-05-31 |
International Aids Vaccine Initiative |
Soluble hiv-1 envelope glycoprotein trimers
|
|
EP3069730A3
(en)
|
2015-03-20 |
2017-03-15 |
International Aids Vaccine Initiative |
Soluble hiv-1 envelope glycoprotein trimers
|
|
US9931394B2
(en)
|
2015-03-23 |
2018-04-03 |
International Aids Vaccine Initiative |
Soluble HIV-1 envelope glycoprotein trimers
|